Suicide and Self-Harm Events With GLP-1 Receptor Agonists in Adults With Diabetes or Obesity: A Systematic Review and Meta-Analysis
6XOX: Kawai T, Sun B, Yoshino H, Feng D, Suzuki Y, Fukazawa M, Nagao S, Wainscott DB, Showalter AD, Droz BA, Kobilka TS, Coghlan MP, Willard FS, Kawabe Y, Kobilka BK, Sloop KW
Tirzepatide was only approved for weight loss two and a half years ago, so there just [hasnt been enough time] to see an effect for a disease like cancer
Protein-first approach: Minimum 0.7-1.0g protein per pound of body weight daily
This makes it appropriate for patients with cardiovascular concerns, anxiety, or a history that contraindicates stimulant use
metformin, which treats insulin resistance